388 related articles for article (PubMed ID: 28749773)
1. Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (
Rueangweerayut R; Bancone G; Harrell EJ; Beelen AP; Kongpatanakul S; Möhrle JJ; Rousell V; Mohamed K; Qureshi A; Narayan S; Yubon N; Miller A; Nosten FH; Luzzatto L; Duparc S; Kleim JP; Green JA
Am J Trop Med Hyg; 2017 Sep; 97(3):702-711. PubMed ID: 28749773
[TBL] [Abstract][Full Text] [Related]
2. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
[TBL] [Abstract][Full Text] [Related]
3. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
[TBL] [Abstract][Full Text] [Related]
4. Tafenoquine and G6PD: a primer for clinicians.
Chu CS; Freedman DO
J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30941413
[TBL] [Abstract][Full Text] [Related]
5. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
6. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
[TBL] [Abstract][Full Text] [Related]
7. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
[TBL] [Abstract][Full Text] [Related]
8. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
Chu CS; Bancone G; Nosten F; White NJ; Luzzatto L
Malar J; 2018 Mar; 17(1):101. PubMed ID: 29499733
[TBL] [Abstract][Full Text] [Related]
9. Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Sharma R; Sharma H; Jones S; Borghini-Fuhrer I; Domingo GJ; Gibson RA; Rolfe K; Tan L; Fiţa IG; Chen C; Bird P; Pingle A; Duparc S
Malar J; 2024 May; 23(1):145. PubMed ID: 38741094
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness Analysis of Sex-Stratified
Devine A; Howes RE; Price DJ; Moore KA; Ley B; Simpson JA; Dittrich S; Price RN
Am J Trop Med Hyg; 2020 Jul; 103(1):394-403. PubMed ID: 32372747
[TBL] [Abstract][Full Text] [Related]
11. Operational effectiveness of tafenoquine and primaquine for the prevention of Plasmodium vivax recurrence in Brazil: a retrospective observational study.
Brito M; Rufatto R; Brito-Sousa JD; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Batista Pereira D; Lacerda M
Lancet Infect Dis; 2024 Jun; 24(6):629-638. PubMed ID: 38452779
[TBL] [Abstract][Full Text] [Related]
12. Hemolytic Dynamics of Weekly Primaquine Antirelapse Therapy Among Cambodians With Acute Plasmodium vivax Malaria With or Without Glucose-6-Phosphate Dehydrogenase Deficiency.
Taylor WRJ; Kheng S; Muth S; Tor P; Kim S; Bjorge S; Topps N; Kosal K; Sothea K; Souy P; Char CM; Vanna C; Ly P; Khieu V; Christophel E; Kerleguer A; Pantaleo A; Mukaka M; Menard D; Baird JK
J Infect Dis; 2019 Oct; 220(11):1750-1760. PubMed ID: 31549159
[TBL] [Abstract][Full Text] [Related]
13. Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.
LaRue N; Kahn M; Murray M; Leader BT; Bansil P; McGray S; Kalnoky M; Zhang H; Huang H; Jiang H; Domingo GJ
Am J Trop Med Hyg; 2014 Oct; 91(4):854-861. PubMed ID: 25071003
[TBL] [Abstract][Full Text] [Related]
14. Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial.
Taylor WR; Olupot-Olupot P; Onyamboko MA; Peerawaranun P; Weere W; Namayanja C; Onyas P; Titin H; Baseke J; Muhindo R; Kayembe DK; Ndjowo PO; Basara BB; Bongo GS; Okalebo CB; Abongo G; Uyoga S; Williams TN; Taya C; Dhorda M; Tarning J; Dondorp AM; Waithira N; Fanello C; Maitland K; Mukaka M; Day NJP
Lancet Infect Dis; 2023 Apr; 23(4):471-483. PubMed ID: 36462528
[TBL] [Abstract][Full Text] [Related]
15. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
[TBL] [Abstract][Full Text] [Related]
16. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.
Beutler E; Duparc S;
Am J Trop Med Hyg; 2007 Oct; 77(4):779-89. PubMed ID: 17978087
[TBL] [Abstract][Full Text] [Related]
17. Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial.
Chen I; Diawara H; Mahamar A; Sanogo K; Keita S; Kone D; Diarra K; Djimde M; Keita M; Brown J; Roh ME; Hwang J; Pett H; Murphy M; Niemi M; Greenhouse B; Bousema T; Gosling R; Dicko A
J Infect Dis; 2018 Mar; 217(8):1298-1308. PubMed ID: 29342267
[TBL] [Abstract][Full Text] [Related]
18. In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals.
Shekalaghe SA; ter Braak R; Daou M; Kavishe R; van den Bijllaardt W; van den Bosch S; Koenderink JB; Luty AJ; Whitty CJ; Drakeley C; Sauerwein RW; Bousema T
Antimicrob Agents Chemother; 2010 May; 54(5):1762-8. PubMed ID: 20194698
[TBL] [Abstract][Full Text] [Related]
19. Operational feasibility of Plasmodium vivax radical cure with tafenoquine or primaquine following point-of-care, quantitative glucose-6-phosphate dehydrogenase testing in the Brazilian Amazon: a real-life retrospective analysis.
Brito M; Rufatto R; Murta F; Sampaio V; Balieiro P; Baía-Silva D; Castro V; Alves B; Alencar A; Duparc S; Grewal Daumerie P; Borghini-Fuhrer I; Jambert E; Peterka C; Edilson Lima F; Carvalho Maia L; Lucena Cruz C; Maciele B; Vasconcelos M; Machado M; Augusto Figueira E; Alcirley Balieiro A; Menezes A; Ataídes R; Batista Pereira D; Lacerda M
Lancet Glob Health; 2024 Mar; 12(3):e467-e477. PubMed ID: 38365417
[TBL] [Abstract][Full Text] [Related]
20. Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression.
Kalnoky M; Bancone G; Kahn M; Chu CS; Chowwiwat N; Wilaisrisak P; Pal S; LaRue N; Leader B; Nosten F; Domingo GJ
Eur J Haematol; 2018 Mar; 100(3):294-303. PubMed ID: 29240263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
